Prevalence of Chronic Obstructive Pulmonary Disease according to BTS, ERS, GOLD and ATS Criteria in Relation to Doctor’s Diagnosis, Symptoms, Age, Gender, and Smoking Habits

Background: Guidelines and standards for diagnosis and management of chronic obstructive pulmonary disease (COPD) have been presented by different national and international societies, but the spirometric criteria for COPD differ between guidelines. Objectives: To estimate prevalence of COPD using the guidelines of the British Thoracic Society (BTS), the European Respiratory Society (ERS), the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and the American Thoracic Society (ATS). Further, to evaluate reported airway symptoms, contacts with health care providers, and physician diagnosis of COPD in relation to the respective criteria, and gender differences. Method: In 1992 a postal questionnaire was sent to a random sample of adults aged 20–69 years, 4,851 (85%) out of 5,681 subjects responded. In 1994–1995 a random sample of the responders, 970 subjects, were invited to a structured interview and a lung function test; 666 (69%) participated. Results: The prevalence of COPD was 7.6, 14.0, 14.1, 12.2 and 34.1% according to BTS, ERS, GOLD, clinical ATS (with symptoms or physician diagnosis), and spirometric ATS criteria, respectively. Prevalent COPD was related to age, smoking habits and family history of obstructive airway disease but not to gender. Physician diagnosis of chronic bronchitis or emphysema was only reported by 16.3, 12.2, 11.0, 23.4 and 8.2% of subjects fulfilling the respective criteria, though a majority reported airway symptoms. Conclusion: The main determinants for prevalent COPD were age, smoking habits and spirometric criteria of COPD. Though a majority reported airway symptoms and contact with health care providers due to respiratory complaints, only a minority was diagnosed as having COPD, indicating a large underdiagnosis.

[1]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[2]  A. Gulsvik,et al.  Sex differences in lung vulnerability to tobacco smoking , 2003, European Respiratory Journal.

[3]  A. Gulsvik,et al.  Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly , 2003, European Respiratory Journal.

[4]  A. Iqbal,et al.  Interpreting COPD prevalence estimates: what is the true burden of disease? , 2003, Chest.

[5]  R. Buhl,et al.  Newly Diagnosed Chronic Obstructive Pulmonary Disease , 2003, Respiration.

[6]  K Larsson,et al.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2003, Respiratory medicine.

[7]  R. Buhl,et al.  Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. , 2003, Respiration; international review of thoracic diseases.

[8]  A. Buist,et al.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.

[9]  M. Decramer,et al.  Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey , 2002, European Respiratory Journal.

[10]  A. Buist Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[11]  J. Vestbo,et al.  Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? , 2002, American journal of respiratory and critical care medicine.

[12]  D. Mannino COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.

[13]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.

[14]  D. Tashkin,et al.  Gender bias in the diagnosis of COPD. , 2001, Chest.

[15]  A. Gulsvik,et al.  The global burden and impact of chronic obstructive pulmonary disease worldwide. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[16]  B. Lundbäck,et al.  Smoking, respiratory symptoms, and diseases : a comparative study between northern Sweden and northern Finland: report from the FinEsS study. , 2001, Chest.

[17]  G. Viegi,et al.  Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) , 2001, Respiration.

[18]  A. Lindberg,et al.  Obstructive sleep apnoea syndrome is common in subjects with chronic bronchitis. Report from the Obstructive Lung Disease in Northern Sweden studies. , 2001, Respiration; international review of thoracic diseases.

[19]  E. Silverman,et al.  Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[20]  M. Miravitlles,et al.  Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. , 2000, Chest.

[21]  N. Pride,et al.  Recent trends in physician diagnosed COPD in women and men in the UK , 2000, Thorax.

[22]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[23]  P. Calverley,et al.  COPD: early detection and intervention. , 2000, Chest.

[24]  G. Viegi,et al.  Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. , 2000, Chest.

[25]  M. Bottai,et al.  Smooth reference equations for slow vital capacity and flow-volume curve indexes. , 2000, American journal of respiratory and critical care medicine.

[26]  S. Hurd,et al.  The impact of COPD on lung health worldwide: epidemiology and incidence. , 2000, Chest.

[27]  W. Bailey,et al.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.

[28]  B. Lundbäck,et al.  Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. , 1999, Respiratory medicine.

[29]  D. Brooks,et al.  Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. , 1999, Chest.

[30]  M. Miravitlles,et al.  Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo , 1999 .

[31]  M. Miravitlles,et al.  [Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation]. , 1999, Archivos de bronconeumologia.

[32]  C. van Weel,et al.  Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. , 1998, American journal of respiratory and critical care medicine.

[33]  BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease , 1997, Thorax.

[34]  Denmark,et al.  Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study , 2002 .

[35]  P. Sly,et al.  Allergic respiratory disease: strategic targets for primary prevention during childhood. , 1997, Thorax.

[36]  J. Vestbo,et al.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.

[37]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[38]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[39]  J. Schouten,et al.  Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. , 1994, The European respiratory journal.

[40]  B. Forsberg,et al.  Epidemiology of respiratory symptoms, lung function and important determinants. Report from the Obstructive Lung Disease in Northern Sweden Project. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[41]  X. Xu,et al.  Gender difference in smoking effects on adult pulmonary function. , 1994, The European respiratory journal.

[42]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[43]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[44]  D. Dockery,et al.  Longitudinal lung function decline in subjects with respiratory symptoms. , 1992, The American review of respiratory disease.

[45]  A. Gulsvik,et al.  Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. , 1991, Thorax.

[46]  L. Nyström,et al.  Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. , 1991, The European respiratory journal.

[47]  N Poisson,et al.  Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. , 1989, The European respiratory journal.

[48]  P. Schnohr,et al.  Effects of smoking and changes in smoking habits on the decline of FEV1. , 1989, The European respiratory journal.

[49]  E. Bleecker,et al.  Evaluation of impairment/disability secondary to respiratory disorders. American Thoracic Society. , 2015, The American review of respiratory disease.

[50]  ATS statement--Snowbird workshop on standardization of spirometry. , 1979, The American review of respiratory disease.

[51]  M. Lebowitz,et al.  Tucson epidemiologic study of obstructive lung diseases. I: Methodology and prevalence of disease. , 1975, American journal of epidemiology.

[52]  E BERGLUND,et al.  Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. , 2009, Acta medica Scandinavica.